Proficio Capital Partners’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
Other funds holding ITOS
Proficio Capital Partners's ITOS Position: Q3 2025 in Review
Proficio Capital Partners sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 24,865 shares — an estimated $248K sold.
Proficio Capital Partners first reported a position in ITOS in Q2 2025 and held it in 1 quarter. The position peaked at $248K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.
- Proficio Capital Partners reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
- Proficio Capital Partners sold 24,865 iTeos Therapeutics shares in Q3 2025, an estimated $248K.
- Proficio Capital Partners first reported a position in iTeos Therapeutics in Q2 2025 and held it in 1 quarter.
- Proficio Capital Partners's iTeos Therapeutics position peaked at $248K in Q2 2025.
- 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.
Based on Proficio Capital Partners's 13F filing for Q3 2025, filed 12 Nov 2025.